Clinical Correspondence
Successful treatment of erythema nodosum leprosum with upadacitinib and roflumilast
Miguel Mansilla-Polo,
Corresponding Author
Miguel Mansilla-Polo
Department of Dermatology, Hospital Universitario y Politécnico La Fe, Valencia, Spain
Instituto de Investigación Sanitaria (IIS) La Fe, Valencia, Spain
Search for more papers by this author Carlos Abril-Pérez,
Carlos Abril-Pérez
Department of Dermatology, Hospital Universitario y Politécnico La Fe, Valencia, Spain
Instituto de Investigación Sanitaria (IIS) La Fe, Valencia, Spain
Search for more papers by this author Daniel Martín-Torregrosa,
Daniel Martín-Torregrosa
Department of Dermatology, Hospital Universitario y Politécnico La Fe, Valencia, Spain
Instituto de Investigación Sanitaria (IIS) La Fe, Valencia, Spain
Search for more papers by this author Rafael Botella-Estrada,
Rafael Botella-Estrada
Department of Dermatology, Hospital Universitario y Politécnico La Fe, Valencia, Spain
Instituto de Investigación Sanitaria (IIS) La Fe, Valencia, Spain
Universitat de València, Valencia, Spain
Search for more papers by this author Ignacio Torres-Navarro,
Ignacio Torres-Navarro
Department of Dermatology, Hospital Universitario y Politécnico La Fe, Valencia, Spain
Instituto de Investigación Sanitaria (IIS) La Fe, Valencia, Spain
Search for more papers by this author
Miguel Mansilla-Polo,
Corresponding Author
Miguel Mansilla-Polo
Department of Dermatology, Hospital Universitario y Politécnico La Fe, Valencia, Spain
Instituto de Investigación Sanitaria (IIS) La Fe, Valencia, Spain
Search for more papers by this author Carlos Abril-Pérez,
Carlos Abril-Pérez
Department of Dermatology, Hospital Universitario y Politécnico La Fe, Valencia, Spain
Instituto de Investigación Sanitaria (IIS) La Fe, Valencia, Spain
Search for more papers by this author Daniel Martín-Torregrosa,
Daniel Martín-Torregrosa
Department of Dermatology, Hospital Universitario y Politécnico La Fe, Valencia, Spain
Instituto de Investigación Sanitaria (IIS) La Fe, Valencia, Spain
Search for more papers by this author Rafael Botella-Estrada,
Rafael Botella-Estrada
Department of Dermatology, Hospital Universitario y Politécnico La Fe, Valencia, Spain
Instituto de Investigación Sanitaria (IIS) La Fe, Valencia, Spain
Universitat de València, Valencia, Spain
Search for more papers by this author Ignacio Torres-Navarro,
Ignacio Torres-Navarro
Department of Dermatology, Hospital Universitario y Politécnico La Fe, Valencia, Spain
Instituto de Investigación Sanitaria (IIS) La Fe, Valencia, Spain
Search for more papers by this author
First published: 06 June 2024
No abstract is available for this article.
References
- 1Chen KH, Lin CY, Su SB, Chen KT. Leprosy: a review of epidemiology, clinical diagnosis, and management. J Trop Med. 2022; 2022(4):8652062.
- 2Scollard DM, Adams LB, Gillis TP, Krahenbuhl JL, Truman RW, Williams DL. The continuing challenges of leprosy. Clin Microbiol Rev. 2006; 19(2): 338–381.
- 3Abril-Pérez C, Palacios-Diaz RD, Navarro-Mira MÁ, Botella-Estrada R. Successful treatment of erythema nodosum leprosum with apremilast. Dermatol Ther. 2022; 35(3):e15258.
- 4Mohamed MF, Bhatnagar S, Parmentier JM, Nakasato P, Wung P. Upadacitinib: mechanism of action, clinical, and translational science. Clin Transl Sci. 2023; 17(1):e13688.
- 5Mansilla-Polo M, Gimeno E, Morgado-Carrasco D. Topical and oral roflumilast in dermatology: a narrative review. Actas Dermosifiliogr. 2024; 115(3): 265–279.
